PMC3573818_01
MRI at diagnosis of MC. Bulky masses of 2.5 x 1.9 cm in maximum size are located between the cranial bone and the cerebrum (arrows).
cro-0006-0001-g01.jpg
PMC3573818_01_cro-0006-0001-g01.jpg
F1
In May 2011, she developed a tongue deviation; magnetic resonance imaging (MRI) showed multiple leptomeningeal metastases (fig. 1).
Timelines of therapy and transition of tumor marker levels of CEA and CA15-3. After receiving capecitabine, both CEA and CA15-3 were markedly decreased.
cro-0006-0001-g02.jpg
PMC3573818_01_cro-0006-0001-g02.jpg
F2
Since she had started receiving capecitabine, CA15-3 and CEA levels gradually reduced (fig. 2), and MRI showed reductions of the leptomeningeal lesions (fig. 3).